Trial Holdings News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.12.24	Mastercard settlement puts UK class action lawsuits on trial (Financial Times)
04.12.24	Ex-Trafigura COO takes stand in bribery trial (Financial Times)
03.12.24	Trafigura loses attempt to have star witness struck from bribery trial (Financial Times)
03.12.24	Trafigura loses attempt to have star witness struck from bribery trial (Financial Times)
28.11.24	LVMH chief confronts leftwing MP in illegal spying trial (Financial Times)
27.11.24	LVMH’s Bernard Arnault summoned to court in trial of France’s former spy chief (Financial Times)
22.11.24	US indictment of Gautam Adani puts India Inc’s reputation on trial (Financial Times)
17.11.24	Novo Nordisk readies trial results for next-generation weight-loss drug (Financial Times)
10.09.24	AstraZeneca shares hit by lung cancer drug trial results (Financial Times)
09.09.24	US accuses Google of dominating ad tech market as antitrust trial begins (Financial Times)
27.08.24	Kroger-Albertsons’ merger trial raises questions over US shopping habits (Financial Times)
20.08.24	Chris Morvillo: trial lawyer who helped Mike Lynch walk free (Financial Times)
20.08.24	Jonathan Bloomer: City executive who was key witness in Lynch trial (Financial Times)
16.08.24	BioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trial (Financial Times)
13.08.24	EU rules threaten to cut new treatments for rare diseases (Financial Times)
03.08.24	Brain implant made from graphene is set to begin UK clinical trial (Financial Times)
01.07.24	Boeing to plead guilty to fraud or face criminal trial under DoJ offer (Financial Times)
24.06.24	US biotech Alnylam hails positive trial results for heart disease drug (Financial Times)
10.06.24	Moderna hails successful trial of combined Covid and flu shot (Financial Times)
09.06.24	The conclusion of EU votes and Hunter Biden’s trial (Financial Times)
07.06.24	FirstFT: UK tech pioneer Mike Lynch acquitted in US fraud trial (Financial Times)
07.06.24	FirstFT: UK tech pioneer Mike Lynch acquitted in US fraud trial (Financial Times)
06.06.24	Former Autonomy chief Mike Lynch acquitted in US fraud trial (Financial Times)
04.06.24	BBVA raises fresh capital after prosecutor pushes for spying trial (Financial Times)
31.05.24	FirstFT: Trump found guilty on all counts in ‘hush money’ trial (Financial Times)
31.05.24	FirstFT: Trump found guilty on all counts in ‘hush money’ trial (Financial Times)
30.05.24	US close to deal to bankroll Moderna bird flu vaccine trial (Financial Times)
22.05.24	Star witness testifies at Archegos trial: ‘Do whatever it takes to get the cash’ (Financial Times)
21.05.24	Prince Harry fails in attempt to include Rupert Murdoch in phone hacking trial (Financial Times)
09.05.24	UK shelves plan for country’s biggest hydrogen home heating trial (Financial Times)
08.05.24	Bill Hwang on trial (Financial Times)
07.05.24	‘To what end?’: the murky question of Bill Hwang’s motive in Archegos trial (Financial Times)
07.05.24	‘To what end?’: the murky question of Bill Hwang’s motive in Archegos trial (Financial Times)
02.05.24	Google defends ‘better’ search product as US antitrust trial wraps up (Financial Times)
01.05.24	Harvey Weinstein will face a new trial in New York this year (Financial Times)
26.04.24	Former PR adviser handed 3-year insider trading sentence in ‘breakfast trust’ trial (Financial Times)
26.04.24	Former PR adviser handed 3-year insider trading sentence in ‘breakfast trust’ trial (Financial Times)
21.04.24	Opening arguments begin in Trump trial (Financial Times)
17.04.24	Eli Lilly weight-loss drug found to address sleep apnoea in trial (Financial Times)
15.04.24	Hedge fund accused of masterminding tax fraud in £1.4bn High Court trial (Financial Times)
18.03.24	Autonomy founder Mike Lynch called ‘driving force’ of ‘massive fraud’ in US trial (Financial Times)
17.03.24	Mike Lynch goes on trial in US over Silicon Valley’s ‘largest fraud’ (Financial Times)
05.03.24	Trial begins for Vietnamese property tycoon accused of $12bn fraud (Financial Times)
29.02.24	UK government to trial ‘red box’ AI tools to improve ministerial efficiency (Financial Times)
27.02.24	Viking Therapeutics shares more than double on ‘statistically significant’ weight-loss trial results (Financial Times)
06.02.24	Big Pharma still needs trial success to overcome looming patent panic (Financial Times)
04.02.24	Ex-Clifford Chance lawyer acquitted in FCA insider trading trial (Financial Times)
04.02.24	Ex-Clifford Chance lawyer acquitted in FCA insider trading trial (Financial Times)
28.01.24	GSK refuses to join Ireland’s mother and baby home compensation scheme (Financial Times)
28.01.24	GSK refuses to join Ireland’s mother and baby home compensation scheme (Financial Times)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Trial Holdings Inc. Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten